Search Results

Site Search

COVID-19: The pandemic that's forever changed laboratory testing - Insights

Since March 2020, the COVID-19 pandemic has had a lasting impact on the lives of millions of people around the world, including the many brave health care workers who risked their own health to provide lifesaving care to those infected by...

Phlebotomy Top Gun - Insights

In this month's "Hot Topic," Brad Karon, M.D., Ph.D., reviews pediatric venipuncture volumes in this year’s Phlebotomy Top Gun case-based presentation as requested by previous Phlebotomy conference attendees.

Pathways Case Studies: September 2019 - Insights

Mayo Clinic laboratory experts share five case studies in this month’s “PathWays” post and are challenging you to test your laboratory genetics & genomics, bone & soft tissue, renal, infectious disease, and gastroenterology pathology...

Antifungal Drug Susceptibility Testing of Yeast: A Primer for Beginners - Insights

In this month’s “Hot Topic,” Nancy Wengenack, Ph.D., discusses susceptibility testing of yeast for those who are considering performing it in their laboratory, perhaps for the first time, or for those who choose to send their yeast isolates...

CPT codes and LOINC update: December 2024 - Insights

This will be the last CPT Codes and LOINC update. Read why.

Canada - Insights

Mayo Clinic Laboratories' approach to vector-borne disease testing uses expert-developed algorithms to streamline test selection. Including assays for tick- and mosquito-borne illness, our comprehensive vector-borne diseases test menu can...

https://news.mayocliniclabs.com/mclinsights-record-of-viewing/certificate/105079/

Record of Viewing (Name of Viewer) Cytogenetic Testing for Pediatric Patients With Hematologic Malignancies Released by Mayo Clinic Laboratories 11/6/2023 Date Viewed: 8/4/2025 Length of Program: 19.5 minutes

Pathways Case Studies: April 2021 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for April include the following sub-specialties: Genitourinary Pathology,...

Preeclampsia - Insights

Our serum test is the first preeclampsia-specific test that can be used to stratify patients into low- or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features.

STAT testing - Insights

STAT testing is available on a limited basis for patients with a suspected or known inborn error of metabolism when there is an increased risk of illness or death due to metabolic decompensation or when testing will allow for emergent...

Weeding Through the Information: Interpreting Laboratory Tests to Determine New vs. Residual Use of Marijuana - Insights

In this month's "Hot Topic," Paul Jannetto, Ph.D., identifies how to determine new vs. residual use of marijuana in a patient, and teaches how to calculate the carboxy-tetrahydrocannabinol (carboxy-THC) to creatinine ratio along with a...

Pathways Case Studies: October 2022 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for October include the following sub-specialties: Cardiovascular Pathology,...

Perspectives Archives - Page 3 of 9 - Insights

Skip to Content MayoACCESS MayoLINK...

Perspectives Archives - Page 4 of 9 - Insights

Skip to Content MayoACCESS MayoLINK...

Perspectives Archives - Page 2 of 9 - Insights

Skip to Content MayoACCESS MayoLINK...

Research Roundup Archives - Page 4 of 29 - Insights

Skip to Content MayoACCESS MayoLINK...

Research Archives - Page 4 of 33 - Insights

Skip to Content MayoACCESS MayoLINK...

Research Archives - Page 32 of 33 - Insights

Skip to Content MayoACCESS MayoLINK...

Perspectives Archives - Page 8 of 9 - Insights

Skip to Content MayoACCESS MayoLINK...

Staffing to Workload in Phlebotomy Areas: Minimum Staffing Levels - Insights

Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on minimum-staffing levels, which can override the calculated staffing needs by adding staff to meet potential demands.

June 2023 - Neuropathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Neuropathology.

Research Archives - Page 25 of 33 - Insights

Skip to Content MayoACCESS MayoLINK...

People Archives - Page 8 of 35 - Insights

Skip to Content MayoACCESS MayoLINK...

Research Archives - Page 29 of 33 - Insights

Skip to Content MayoACCESS MayoLINK...

Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 6 - Insights

This week’s Research Roundup highlights an international assessment of event-free survival at 24 months and subsequent survival in peripheral T-cell lymphoma.

Mayo Clinic Laboratory and pathology research roundup: November 29 - Insights

This week's research roundup features: AMPK: The key to ischemia-reperfusion injury

New Tests Launched Archives - Page 4 of 6 - Insights

Skip to Content MayoACCESS MayoLINK...

Staphylococcus species assay [Test in Focus] - Insights

Audrey Schuetz, M.D., discusses Mayo Clinic Laboratories' PCR assay that identifies two recently described staphylococcus species. The assay is unique in its ability to distinguish the new organisms from Staphylococcus aureus, providing...

Testing Archives - Page 8 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 7 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Education - Insights

Learn more about educational offerings available to primary clients of Mayo Clinic Laboratories.

Cardiology - Insights

Mayo Clinic Laboratories’ comprehensive menu of genetic cardiovascular testing provides results that support gene-based strategies to manage inherited cardiovascular disease.

Hospitals and health systems - Insights

Mayo Clinic Laboratories can help hospital laboratories leverage the power of their labs through advanced, high-quality testing, customized consultative services, and tailored business solutions.

Ceramide testing helps shape individualized heart health treatment plan: Mark Kocak - Insights

An avid runner and fitness buff, Mark Kocak didn’t think he needed medication for his high cholesterol and hypertension. After coming to Mayo Clinic for ceramide testing, Mark knew exercise alone would not be enough to him on a path toward...

Prostate Health Index (phi) [Test in Focus] - Insights

Useful For Assessing the patient’s probability of having detectable prostate cancer when totalprostate specific antigen (PSA) concentrations are between

Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights

The standard test for the diagnosis of narcolepsy is the multiple sleep latency test (MSLT). The MSLT is a complex test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT...

CPT codes and LOINC update: February 2023 - Insights

This page shows updates posted to Mayo Clinic Labs during the month of February.

Precision oncology therapeutics - Insights

Learn more about our personalized cancer testing that establishes patients’ genetic profiles and allows physicians to select medications that optimize therapeutic efficacy while minimizing harmful reactions.

Whole genome sequencing - Insights

Check out Mayo Clinic Laboratories’ whole genome testing, a next-generation sequencing assay that interrogates nearly every base pair of an individual’s DNA, including the mitochondrial genome.

wes-wgs-information-test-ordering-guide.pdf

GEN ETICS +Turnaround time begins upon receipt of all samples and required paperwork. ^Whole blood is the preferred specimen type. ŧCPT codes 81416 or 81426 are applied to proband when a family member comparator is submitted. This code...

Alzheimer's Disease Testing - Mayo Clinic Laboratories

We have developed an innovative evaluation for Alzheimer's disease, which uses CSF biomarkers to achieve a high concordance with amyloid PET scan.

Pathways Case Studies: September 2023 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for September include the following sub-specialties: Cardiovascular Pathology,...

Bone and Soft Tissue Pathology Services at Mayo Cinic Laboratories

At Mayo Clinic, we excel in our approach to work collaboratively with radiology, surgery, and clinical practice to bring the highest quality.

Mayo Clinic Researchers Develop Prediction Tool for Kidney Stones - Insights

Mayo Clinic researchers are tracking the familiar characteristics of kidney stone formers in an online prediction tool that could help sufferers anticipate if they'll experience future episodes.

CPT codes and LOINC update: August 2024 - Insights

This page lists updates posted to Mayo Clinic Labs during the month of August.

Featured new tests - Insights

In 2020, Mayo Clinic Laboratories launched more than 100 new tests. Driven by a patient-centered philosophy, our experts, laboratories, and facilities make it possible to develop new tests that transform medicine worldwide.

US: West - Insights

Mayo Clinic Laboratories vector-borne disease testing is guided by an algorithm approach that supports the right test in the right region. Our comprehensive suite of vector-borne disease tests includes testing for the most commonly...

Nailing the Suspect: The Prevalence of Autoimmune Encephalitis Compared with Infectious Encephalitis - Insights

For people with encephalitis, rapid treatment of their acute brain inflammation is critical for avoiding devastating physical and cognitive deficits. But appropriate treatment requires identifying the culprit causing the symptoms.

IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights

In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.

US: South - Insights

Mayo Clinic Laboratories' algorithmic approach to vector-borne disease testing supports the selection of the right test for the right region. Our full suite of vector-borne disease tests includes expert-developed assays for the most...